Whatever the outcome of the current House-Senate conference onMedicare legislation, taxpayers can depend on one thing: The costprojections of the Medicare drug entitlement keep rising.
Members of Congress should undertake structural improvements inMedicare that will ensure seniors have access to medical innovationand technology within a market-based framework that ensurescompetition, choice, and quality.
With the last remnants of spending restraint fading fast inCongress, fiscal discipline will be restored only if the WhiteHouse declares a defined limit on government spending for the nextfiscal year. The President should make it clear that he willexercise his veto authority.